Powder: -20°C for 3 years | In solvent: -80°C for 2 years
AZD8926 is a potent and selective inhibitor of GSK3β(glycogen synthase kinase-3β). AZD8926 is potential for treating Alzheimer’s disease (AD), schizophrenia, and chronic as well as acute neurodegenerative diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 1,270.00
$ 1,016.00
|
|
50 mg | 8-10 weeks | $ 2,580.00
$ 2,064.00
|
|
100 mg | 8-10 weeks | $ 3,400.00
$ 2,720.00
|
Description | AZD8926 is a potent and selective inhibitor of GSK3β(glycogen synthase kinase-3β). AZD8926 is potential for treating Alzheimer’s disease (AD), schizophrenia, and chronic as well as acute neurodegenerative diseases. |
Synonyms | AZD-8926, AZD 8926 |
Molecular Weight | 533.52 |
Formula | C25H27F4N7O2 |
CAS No. | 933785-68-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD8926 933785-68-3 AZD-8926 AZD 8926 inhibitor inhibit